Yuki Yoshizawa
MSc | Senior Investment Advisor – M&A & Medical Technology
Based in Dubai, Yuki Yoshizawa serves as a crucial bridge connecting Japanese medical technology innovation with capital markets in the Gulf region. He specializes in advising on acquisitions, growth equity investments, and joint-venture structures specifically tailored for cutting-edge therapeutic devices.
At MCO I, a Dubai platform dedicated to importing Japanese technology into the GCC, Yuki leads deal sourcing and financing efforts. He plays a key role in headline projects like mediVR KAGURA®, an Osaka University spin-out utilizing immersive VR for neuro-rehabilitation, which is now being deployed in over 120 healthcare facilities worldwide thanks to Yuki's efforts in securing funding and partnerships.
Yuki is a regular speaker at prominent industry events such as MEDTEC Japan and Arab Health. There, he decodes complex topics like reimbursement pathways, Good Manufacturing Practice (GMP) compliance, and ESG-linked valuation models, providing valuable insights for both investors and med-tech founders.